Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.710
+0.100 (6.21%)
At close: Jun 26, 2026, 4:00 PM EDT
1.696
-0.014 (-0.82%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Outlook Therapeutics Employees
Outlook Therapeutics had 17 employees as of September 30, 2025. The number of employees decreased by 6 or -26.09% compared to the previous year.
Employees
17
Change (1Y)
-6
Growth (1Y)
-26.09%
Revenue / Employee
$19,597
Profits / Employee
-$3,585,676
Market Cap
206.68M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Tonix Pharmaceuticals Holding | 142 |
| MediWound | 121 |
| Arcturus Therapeutics Holdings | 111 |
| Nkarta | 108 |
| Compugen | 75 |
| Q32 Bio | 22 |
| Equillium | 15 |
OTLK News
- 12 days ago - Outlook Therapeutics resubmits ONS-5010 biologics license application to FDA - TheFly
- 12 days ago - Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD - GlobeNewsWire
- 26 days ago - Outlook Therapeutics resubmits biologics license application to FDA - TheFly
- 27 days ago - Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg) - GlobeNewsWire
- 27 days ago - Outlook Therapeutics Proxy statement: Proxy filing - Filings
- 27 days ago - Outlook Therapeutics Proxy statement: Proxy filing - Filings
- 4 weeks ago - Outlook Therapeutics announces pricing of $5M registered direct offering - TheFly
- 4 weeks ago - Outlook to sell 8.54M shares at 58.55c in registered direct offering - TheFly